C
Chugai Pharmaceutical
Tokyo, Japan
Founded 1925 TSE: 4519
Nanomedicine Drug Delivery Protein Engineering Nanobiomarkers Regenerative Medicine Cancer Nanotherapy
About
Antibody engineering and innovative drug delivery
Company Details
- Type
- public
- Employees
- 7500+
- Funding
- Public
Key Products
- Hemlibra
- Enspryng